Preventive radiation may stop bone events before they start — a trial puts it to the test

NCT ID NCT07733193

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether giving radiation therapy early — before symptoms appear — can reduce the risk of bone complications (like fractures or spinal cord pressure) in people with solid tumors that have spread to the bone. Participants have bone lesions that are considered at intermediate risk for such events. Half will receive preventive radiation, while the other half will receive standard care and be monitored closely. The goal is to see if early treatment can prevent these painful and serious events.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
prophylactic radiation therapy
What this could lead to
If it works, this could establish a new standard for preventing painful bone complications in patients with cancer that has spread to the bones.
What could go wrong
This is a phase 3 trial, but the benefit of preventive radiation in intermediate-risk patients is unproven, and radiation itself carries risks like fatigue or local side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Henri Becquerel

    Rouen, France

  • Institut de Cancérologie de Lorraine

    Nancy, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.